top of page

Mapping autism spectrum disorder protein interactions with the director of UCSF's QBI

blonca9
Dec 4, 2023
1 min read

Nevan Krogan, Director of the Quantitative Biosciences Institute at UCSF, expands on work posted to bioRxiv today showing how mapping protein-protein interactions involving 100 autism spectrum disease risk genes could advance the understanding of autism biology.

Link: A foundational atlas of autism protein interactions reveals molecular convergence

This work was led by Dr. Krogan and the following collaborators:

Matthew State - Department of Psychiatry and Behavioral Sciences at the Weill Institute for Neurosciences at UCSF

Jeremy Willsey - Calico Life Sciences

Tomasz Nowakowski - Departments of Neurological Surgery and Anatomy at UCSF

Recent Posts

See All

Vida Ventures named Matt Cohen and Brian Goodman new Managing Directors today. BiotechTV caught up with Brian in Vida's Boston office

State of Possible: Atlas Venture's Bruce Booth shares his take on the current state of biotech and what it takes to get through difficult times for the industry as an investor and for companies

State of Possible: Cigall Kadoch discusses her pioneering work in chromatin regulation that has led to Foghorn Therapeutics

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Mapping autism spectrum disorder protein interactions with the director of UCSF's QBI

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight